FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281755773> ?p ?o ?g. }

• W4281755773 endingPage "143" @default.
• W4281755773 startingPage "125" @default.
• W4281755773 abstract "There is a shortage of clinical studies examining the efficacy of Nicotinamide Adenine Dinucleotide and Enkephalinase infusions (IV1114589NAD) in treating Substance Use Disorder (SUD).This study aims to provide evidence that IV1114589NAD infusions significantly attenuate substance craving behavior.The study cohort consisted of addicted poly-drug, mixed gender, multi-ethnic individuals resistant to standard treatment. The investigation utilized Likert-Scales to assess behavioral outcomes.Using Wilcoxon signed-rank tests and sign tests, our team detected significant results by comparing baseline to post outcome scores after IV1114589NAD injections: craving scores (P=1.063E-9); anxiety (P=5.487E-7); and depression (P=1.763E-4). A significant reduction in cravings, anxiety, and depression followed a dose-dependent linear trend. Linear trend analyses showed a significant relationship between NAD infusions and decreasing scores for cravings (P=0.015), anxiety (P=0.003), and depression (P=8.74E-5). A urine analysis was conducted on a subset of 40 patients midway through the study to assess relapse; 100% of the urine samples analyzed failed to detect illicit substance use.The opioid crisis in America has claimed close to 800,000 lives since 2004; daily deaths are estimated to stand at 127, and in 2021, over 107,000 deaths were due to overdose. There is an urgency to find safe, side-effect-free solutions. Current interventions, such as Naltrexone implants, are invasive and may interfere with dopamine homeostasis leading to an anti-reward phenomenon. Larger randomized double-blinded placebo-controlled studies are needed to elucidate further the significance of the results presented in this study. The current pilot study provides useful preliminary data regarding the effectiveness of IV1114589NAD infusions in SUD treatment.This pilot study provides significant evidence that NAD infusions are beneficial in the treatment of SUD. This investigation serves as a rationale to extend these findings onto future research investigating the use of NAD/NADH as a stand-alone treatment, especially in patients showing high genetic risk as measured in the Genetic Addiction Risk Severity (GARS) test. Utilizing GARS will help provide a real personalized therapeutic approach to treat Reward Deficiency Syndrome (RDS)." @default.
• W4281755773 created "2022-06-13" @default.
• W4281755773 creator A5012575237 @default.
• W4281755773 creator A5042096725 @default.
• W4281755773 creator A5043563621 @default.
• W4281755773 creator A5048970708 @default.
• W4281755773 creator A5067068796 @default.
• W4281755773 creator A5068205582 @default.
• W4281755773 creator A5077020871 @default.
• W4281755773 creator A5084642438 @default.
• W4281755773 creator A5086871210 @default.
• W4281755773 creator A5087980287 @default.
• W4281755773 date "2022-07-01" @default.
• W4281755773 modified "2023-09-26" @default.
• W4281755773 title "Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases" @default.
• W4281755773 cites W1534930856 @default.
• W4281755773 cites W1589430668 @default.
• W4281755773 cites W1589473129 @default.
• W4281755773 cites W166176618 @default.
• W4281755773 cites W1803077191 @default.
• W4281755773 cites W1962583253 @default.
• W4281755773 cites W1967496421 @default.
• W4281755773 cites W1967695098 @default.
• W4281755773 cites W1973364860 @default.
• W4281755773 cites W1978123771 @default.
• W4281755773 cites W1981634237 @default.
• W4281755773 cites W1987488180 @default.
• W4281755773 cites W1989602840 @default.
• W4281755773 cites W1999842412 @default.
• W4281755773 cites W2000512982 @default.
• W4281755773 cites W2004940502 @default.
• W4281755773 cites W2012220380 @default.
• W4281755773 cites W2013712487 @default.
• W4281755773 cites W2014410471 @default.
• W4281755773 cites W2021968954 @default.
• W4281755773 cites W2024663142 @default.
• W4281755773 cites W2025534559 @default.
• W4281755773 cites W2031050244 @default.
• W4281755773 cites W2041667502 @default.
• W4281755773 cites W2044627849 @default.
• W4281755773 cites W2045462862 @default.
• W4281755773 cites W2045766361 @default.
• W4281755773 cites W2047091643 @default.
• W4281755773 cites W2050084080 @default.
• W4281755773 cites W2055272766 @default.
• W4281755773 cites W2068043284 @default.
• W4281755773 cites W2077228561 @default.
• W4281755773 cites W2078234978 @default.
• W4281755773 cites W2079454681 @default.
• W4281755773 cites W2080079285 @default.
• W4281755773 cites W2084848847 @default.
• W4281755773 cites W2090038734 @default.
• W4281755773 cites W2090854655 @default.
• W4281755773 cites W2102417145 @default.
• W4281755773 cites W2116754256 @default.
• W4281755773 cites W2130971341 @default.
• W4281755773 cites W2136246479 @default.
• W4281755773 cites W2140893911 @default.
• W4281755773 cites W2144747578 @default.
• W4281755773 cites W2151088690 @default.
• W4281755773 cites W2151930363 @default.
• W4281755773 cites W2163839848 @default.
• W4281755773 cites W2174415075 @default.
• W4281755773 cites W2268475073 @default.
• W4281755773 cites W2276800670 @default.
• W4281755773 cites W2396455190 @default.
• W4281755773 cites W2400498678 @default.
• W4281755773 cites W2410110026 @default.
• W4281755773 cites W2413791982 @default.
• W4281755773 cites W2414793365 @default.
• W4281755773 cites W2417655357 @default.
• W4281755773 cites W2419071366 @default.
• W4281755773 cites W2419659366 @default.
• W4281755773 cites W2528829564 @default.
• W4281755773 cites W2548433084 @default.
• W4281755773 cites W2561646545 @default.
• W4281755773 cites W2577393530 @default.
• W4281755773 cites W2588924122 @default.
• W4281755773 cites W2608331258 @default.
• W4281755773 cites W2726346138 @default.
• W4281755773 cites W2758983729 @default.
• W4281755773 cites W2776280150 @default.
• W4281755773 cites W2783913732 @default.
• W4281755773 cites W2790368363 @default.
• W4281755773 cites W2910841397 @default.
• W4281755773 cites W2917876451 @default.
• W4281755773 cites W2984836846 @default.
• W4281755773 cites W2993980773 @default.
• W4281755773 cites W3005772501 @default.
• W4281755773 cites W3008057173 @default.
• W4281755773 cites W3024142281 @default.
• W4281755773 cites W3031982843 @default.
• W4281755773 cites W3130793960 @default.
• W4281755773 cites W3134856384 @default.
• W4281755773 cites W3198882129 @default.
• W4281755773 cites W4207034424 @default.
• W4281755773 cites W4221130370 @default.
• W4281755773 cites W4223998630 @default.

• next